Monitoring and management of patients on therapeutic anticoagulation: A quality improvement initiative
Clinical Medicine(2019)
摘要
Clear national and trust guidelines are available regarding the management of patients receiving anticoagulation therapy (warfarin and low molecular weight heparin (LMWH)). Lack of available evidence for LMWH in renal impairment makes anti-factor Xa monitoring crucial in this population. Two
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要